ConductScience.org, home

Paper33010331

Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation.

Mai X and 4 others. J Control Release, 2021. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation. Papers, record 33010331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33010331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation.
PubMed
Journal
J Control Release
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2021-07-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mai XXiaoxuan
2Chang YYanzhou
3You YYuanyuan
4He LLizhen
5Chen TTianfeng

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
High-Intensity Focused Ultrasound AblationMajor topic
NeoplasmsMajor topic
Pharmaceutical PreparationsMajor topic
Humans
Magnetic Resonance Imaging
Silicon Dioxide

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42199658Nanoplatforms-Enhanced High-Intensity Focused Ultrasound for Cancer Immunotherapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42199658PubMed
41426324Nanoparticle-ultrasound synergy: an emerging theranostic paradigm for breast and gynecologic cancers.Front Oncol2025https://conductscience.org/library/papers/41426324PubMed
41222383Spectral and Acoustic Characterization of Nanoenergetic Devices Based on Sodium Perchlorate-Impregnated Porous Silicon.Nanomaterials (Basel)2025https://conductscience.org/library/papers/41222383PubMed
40698150High intensity forced ultrasound-driven ferroptosis as a strategy for anti-tumor immune priming.Acta Pharm Sin B2025https://conductscience.org/library/papers/40698150PubMed
40503053CeO2 nanozyme-embedded thermal-deformative polymer for site-specific chemotherapy via HIF-1α-P-gp/lipolysis axis reversal.Asian J Pharm Sci2025https://conductscience.org/library/papers/40503053PubMed
40305624Biomimetic elasticity compressed assembly controls rapid intracerebral drug release to reverse microglial dysfunction.Sci Adv2025https://conductscience.org/library/papers/40305624PubMed
40040822Harnessing stimuli-responsive biomaterials for advanced biomedical applications.Exploration (Beijing)2025https://conductscience.org/library/papers/40040822PubMed
39385196US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.J Nanobiotechnology2024https://conductscience.org/library/papers/39385196PubMed
39150483Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials.Mikrochim Acta2024https://conductscience.org/library/papers/39150483PubMed
38659328Application of high intensity focused ultrasound combined with nanomaterials in anti-tumor therapy.Drug Deliv2024https://conductscience.org/library/papers/38659328PubMed
37803412Nanomaterial-Enabled Photothermal Heating and Its Use for Cancer Therapy via Localized Hyperthermia.Small2024https://conductscience.org/library/papers/37803412PubMed
37636983Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors.Mater Today Bio2023https://conductscience.org/library/papers/37636983PubMed
37242696Nanoplatforms Potentiated Ablation-Immune Synergistic Therapy through Improving Local Control and Suppressing Recurrent Metastasis.Pharmaceutics2023https://conductscience.org/library/papers/37242696PubMed
37180717Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors.Front Pharmacol2023https://conductscience.org/library/papers/37180717PubMed
37120558Dual mode imaging guided multi-functional bio-targeted oxygen production probes for tumor therapy.J Nanobiotechnology2023https://conductscience.org/library/papers/37120558PubMed
36650023Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy.J Immunother Cancer2023https://conductscience.org/library/papers/36650023PubMed
35890217Stimuli-Responsive Gold Nanocages for Cancer Diagnosis and Treatment.Pharmaceutics2022https://conductscience.org/library/papers/35890217PubMed
35300712Ultrasound and nanomaterial: an efficient pair to fight cancer.J Nanobiotechnology2022https://conductscience.org/library/papers/35300712PubMed
35027950Aspects of high-performance and bio-acceptable magnetic nanoparticles for biomedical application.Asian J Pharm Sci2021https://conductscience.org/library/papers/35027950PubMed
35004614RNA Hydrogel Combined with MnO2 Nanoparticles as a Nano-Vaccine to Treat Triple Negative Breast Cancer.Front Chem2021https://conductscience.org/library/papers/35004614PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33010331

GET https://conductscience.org/api/papers/v1/33010331/cited_by?page=2